Allergy Therapeutics (Allergy Therapeutics) Effective Interest Rate on Debt % : 27.89% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Allergy Therapeutics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Allergy Therapeutics's annualized positive value of Interest Expense for the quarter that ended in Dec. 2023 was $8.07 Mil. Allergy Therapeutics's average total debt for the quarter that ended in Dec. 2023 was $28.95 Mil. Therefore, Allergy Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 was 27.89%.

Allergy Therapeutics Effective Interest Rate on Debt % Historical Data

The historical data trend for Allergy Therapeutics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Effective Interest Rate on Debt % Chart

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

7.13

6.88

4.46

5.75

10.55

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															3.75	8.76	7.80	18.00	27.89

Competitive Comparison of Allergy Therapeutics's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Allergy Therapeutics's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Allergy Therapeutics's Effective Interest Rate on Debt % falls into.

Allergy Therapeutics Effective Interest Rate on Debt % Calculation

Allergy Therapeutics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jun. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Jun. 2022 )	+	Total Debt (A: Jun. 2023 ))	/ count )
=	-1 * -3.082	/	( (12.967	+	45.441)	/ 2 )
=	-1 * -3.082	/	29.204
=	10.55 %

where

	Total Debt (A: Jun. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	10.174	+	2.793
=	12.967

	Total Debt (A: Jun. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	43.164	+	2.277
=	45.441

Allergy Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Jun. 2023 )	+	Total Debt (Q: Dec. 2023 ))	/ count )
=	-1 * -8.074	/	( (45.441	+	12.468)	/ 2 )
=	-1 * -8.074	/	28.9545
=	27.89 %

where

	Total Debt (Q: Jun. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	43.164	+	2.277
=	45.441

	Total Debt (Q: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	10.253	+	2.215
=	12.468

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Dec. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Allergy Therapeutics (OTCPK:AGYTF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Allergy Therapeutics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Allergy Therapeutics (Allergy Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (OTCPK:AGYTF) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

AGY:UK HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.